Philidor

Showing 5 posts of 5 posts found.

valeant

Former Valeant executive and Philidor CEO charged with fraud

November 18, 2016
Medical Communications, Sales and Marketing Philidor, Valeant, Valeant Pharmaceuticals, fraud

Gary Tanner, former executive, and Andrew Davenport, ex-CEO of Philidor, have been arrested and charged with fraud. Preet Bharara, US …

shutterstock_92671375

Valeant under criminal investigation

August 11, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Philidor, Valeant, investigation

Valeant Pharmaceuticals International is currently under investigation by the US attorney’s office in Manhattan over suspicions that the firm intentionally …

figures_charts

Valeant’s ad hoc committee closes chapter on Philidor controversy

April 5, 2016
Medical Communications, Research and Development, Sales and Marketing Philidor, Valeant, ad hoc, ad hoc committee

Valeant (NYSE: VRX) has announced that the ad hoc committee of the board of directors has finished its review of …

valeant

Valeant ends controversial litigation with R&O Pharmacy

March 10, 2016
Litigation, Philidor, Valeant, controversy, r&o pharmacy, scandal

Valeant has announced that, in conjunction with R&O Pharmacy, its has jointly requested that the Court dismiss the litigation between …

mark_filip

Former Deputy Attorney General called in to advise Valeant after fraud allegations

November 2, 2015
Medical Communications, Sales and Marketing Mark Filip, Philidor, Valeant, fraud

Valeant Pharmaceuticals’ board of directors has appointed former Deputy Attorney General of the United States Mark Filip to advise the …

The Gateway to Local Adoption Series

Latest content